4//SEC Filing
CATALYST PHARMACEUTICALS, INC. 4
Accession 0001161697-15-000446
$CPRXCIK 0001369568operating
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 6:17 PM ET
Size
5.1 KB
Accession
0001161697-15-000446
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Sale
Common stock, par value $0.001 per share
2015-10-23$3.34/sh−22,800$76,152→ 74,131 total
Footnotes (1)
- [F1]Shares were sold principally for the purpose of funding the exercise of stock options that will expire in November 2015. The exercise of the stock options using the proceeds of this sale will be reported in a separate Form 4.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369568
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 6:17 PM ET
- Size
- 5.1 KB